Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Maxipost (BMS 204352) on Cerebral Hemodynamic and Headache in Healthy Volunteers and Migraine Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Migraine patients without aura who fulfill criteria in the international classification of headaches. This does not apply to healthy volunteers.~* 18-60 years.~* 50-90 kg.~* Women of childbearing potential must use adequate contraception.~Exclusion Criteria:~* Headache less than 48 hours before the tests start~* All primary headaches, except migraine without aura for migraine patients, according to international classification of headache~* Daily consumption of drugs of any kind other than oral contraceptives~* Pregnant or nursing women.~* Cardiovascular disease of any kind, including cerebrovascular diseases.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Maxipost (Type: ACTIVE_COMPARATOR): None
- Saline (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).